ELL Antikörper
Kurzübersicht für ELL Antikörper (ABIN2460171)
Target
Alle ELL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Antibody is purified by protein A chromatography method.
-
Immunogen
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human ELL.
-
-
-
-
Applikationshinweise
- ELL antibody can be used for detection of ELL by ELISA at 1:312500. ELL antibody can be used for detection of ELL by western blot at 7.5 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 ?L of distilled water. Final antibody concentration is 1 mg/mL.
-
Konzentration
- 1 mg/mL
-
Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
-
Handhabung
- As with any antibody avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store ELL antibody at -20 °C.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Andere Bezeichnung
- ELL
-
Hintergrund
- ELL was shown to encode a previously uncharacterized elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by polymerase at multiple sites along the DNA. Functionally, ELL resembles Elongin (SIII), a transcription elongation factor regulated by the product of the von Hippel-Lindau (VHL) tumor suppressor gene.
-
Molekulargewicht
- 68 kDa
-
Gen-ID
- 8178
-
NCBI Accession
- NP_006523
-
UniProt
- P55199
Target
-